Boule Diagnostics AB (publ)

Stockholm Stock Exchange BOUL.ST

Boule Diagnostics AB (publ) Net Income for the year ending December 31, 2023: USD 2.47 M

Boule Diagnostics AB (publ) Net Income is USD 2.47 M for the year ending December 31, 2023, a 102.81% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Boule Diagnostics AB (publ) Net Income for the year ending December 31, 2022 was USD 1.22 M, a -52.56% change year over year.
  • Boule Diagnostics AB (publ) Net Income for the year ending December 31, 2021 was USD 2.56 M, a 144.08% change year over year.
  • Boule Diagnostics AB (publ) Net Income for the year ending December 31, 2020 was USD -5.81 M, a -245.51% change year over year.
  • Boule Diagnostics AB (publ) Net Income for the year ending December 31, 2019 was USD 4.00 M, a -13.45% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: BOUL.ST

Boule Diagnostics AB (publ)

Description

Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. The company provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning products under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer and diagnostics systems under the Exigo brand. It sells its products directly in Sweden and the United States, as well as through distributors internationally. The company serves hospitals, clinics, laboratories, healthcare centers and veterinary clinics, and other diagnostics companies. It has operations in Sweden, the United States, Mexico, and Russia. The company was founded in 1956 and is headquartered in Spånga, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 12.37

-2.86%

CRAD-B.ST

C-Rad AB (publ)

USD 2.87

-1.57%

CEVI.ST

CellaVision AB (publ)

USD 19.20

-5.48%

BIOG-B.ST

BioGaia AB (publ)

USD 10.71

-1.60%

CTT.ST

CTT Systems AB (publ)

USD 24.92

-2.16%

StockViz Staff

February 4, 2025

Any question? Send us an email